Diseases & treatment Market Research Reports

Titlepublishedprice

Major Depressive Disorder Therapeutics in Major Developed Markets to 2020 – New Launches and Modest Uptake of New Adjunctive Treatments to Offset Patent Expiries

By GBI Research
"......essive Disorder (MDD) in the major developed markets of the US, the UK, France, Germany, Italy, Spain, Japan and Canada. The report provides an estimation of market size for 2013, along with market forecast until 2020. It also covers disease epidemio......"
1-Oct-2014$4995

Penicillin Markets in China

By AMID
"......r consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry ......"
1-Oct-2014$4000

Global H1N1 Vaccines Market 2014-2018

By Infiniti Research Limited
"...... different animal species such as humans, swine, birds, seals, and horses. Influenza A viruses can be subdivided on the basis of antigenicity of its surface glycoproteins neuraminidase and hemagglutinin. Hemagglutinin component is used by the virus t......"
1-Oct-2014$2500

PharmaPoint: HER2-Positive Breast Cancer – China Drug Forecast and Market Analysis to 2023

By GlobalData
"......tiple settings of the disease including neoadjuvant, adjuvant, first-, second-, third-, and fourth-line metastatic. Currently, treatment rates for HER2-positive breast cancer in China are low, with Roche reporting that approximately 30% of patient......"
30-Sep-2014$4995

Herceptin (HER2-Positive Breast Cancer) – Forecast and Market Analysis to 2023

By GlobalData
"......ent treatment landscape, unmet needs, current pipeline, and commercial opportunities in the HER2-positive breast cancer market, with coverage of multiple settings of the disease including neoadjuvant, adjuvant, first-, second-, third, and fourth-line......"
30-Sep-2014$3495

PharmaPoint: HER2-Positive Breast Cancer – 5EU Drug Forecast and Market Analysis to 2023

By GlobalData
"......tiple settings of the disease including neoadjuvant, adjuvant, first-, second-, third-, and fourth-line metastatic. As in the other seven countries covered in this report, Herceptin is the market leader in France, since it was the first HER2-targe......"
30-Sep-2014$6995

Perjeta (HER2-Positive Breast Cancer) – Forecast and Market Analysis to 2023

By GlobalData
"......t treatment landscape, unmet needs, current pipeline, and commercial opportunities in the HER2-positive breast cancer market, with coverage of multiple settings of the disease including neoadjuvant, adjuvant, first-, second-, third, and fourth-line m......"
30-Sep-2014$3495

Kadcyla (HER2-Positive Breast Cancer) – Forecast and Market Analysis to 2023

By GlobalData
"......t treatment landscape, unmet needs, current pipeline, and commercial opportunities in the HER2-positive breast cancer market, with coverage of multiple settings of the disease including neoadjuvant, adjuvant, first-, second-, third, and fourth-line m......"
30-Sep-2014$3495

Tykerb (HER2-Positive Breast Cancer) – Forecast and Market Analysis to 2023

By GlobalData
"...... treatment landscape, unmet needs, current pipeline, and commercial opportunities in the HER2-positive breast cancer market, with coverage of multiple settings of the disease including neoadjuvant, adjuvant, first-, second-, third, and fourth-line me......"
30-Sep-2014$3495

Neratinib (HER2-Positive Breast Cancer) – Forecast and Market Analysis to 2023

By GlobalData
"......ent treatment landscape, unmet needs, current pipeline, and commercial opportunities in the HER2-positive breast cancer market, with coverage of multiple settings of the disease including neoadjuvant, adjuvant, first-, second-, third, and fourth-line......"
30-Sep-2014$3495
Live Chat
Live Chat by Comm100